Physician profile
Hunter Lee Wolfe
NPI 1013641547
$1,806.95
in general payments reported to CMS, 2019-2025
10 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,670 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,248 · Food and Beverage: $559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,247.87 |
| Food and Beverage | $559.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,280.65 | 2024 | |
| Edwards Lifesciences Corporation | $149.95 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Getinge USA Sales, LLC | $108.79 | 2024 | Vasoview Hemopro 2 |
| Arthrex, INC. | $59.54 | 2024 | |
| Medical Device Business Services, INC. | $58.82 | 2024 | Vistaseal |
| Atricure, INC. | $50.52 | 2024 | |
| Abiomed | $25.49 | 2025 | |
| Kerecis Limited | $24.93 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Medtronic, INC. | $24.85 | 2024 | Avalus |
| Boston Scientific Corporation | $23.41 | 2025 | Eluvia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hunter Wolfe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.